161 related articles for article (PubMed ID: 3319731)
21. Topical minoxidil for male pattern baldness.
Storer JS; Brzuskiewicz J; Floyd H; Rice JC
Am J Med Sci; 1986 May; 291(5):328-33. PubMed ID: 3518451
[TBL] [Abstract][Full Text] [Related]
22. Effect of ultraviolet light on topical minoxidil-induced hair growth in advanced male pattern baldness.
Pestana A; Olsen EA; Delong ER; Murray JC
J Am Acad Dermatol; 1987 May; 16(5 Pt 1):971-6. PubMed ID: 3294945
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Whiting D; Bergfeld W; Miller J; Hordinsky M; Wanser R; Zhang P; Kohut B
J Am Acad Dermatol; 2007 Nov; 57(5):767-74. PubMed ID: 17761356
[TBL] [Abstract][Full Text] [Related]
24. A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.
Tsuboi R; Tanaka T; Nishikawa T; Ueki R; Yamada H; Katsuoka K; Ogawa H; Takeda K
Eur J Dermatol; 2007; 17(1):37-44. PubMed ID: 17324826
[TBL] [Abstract][Full Text] [Related]
25. The safety of topical minoxidil solution in the treatment of pattern baldness: the results of a 27-center trial.
Spindler JR
Clin Dermatol; 1988; 6(4):200-12. PubMed ID: 3063372
[No Abstract] [Full Text] [Related]
26. Efficacy and safety of a new 5% minoxidil formulation in male androgenetic alopecia: A randomized, placebo-controlled, double-blind, noninferiority study.
Blume-Peytavi U; Issiakhem Z; Gautier S; Kottner J; Wigger-Alberti W; Fischer T; Hoffmann R; Tonner F; Bouroubi A; Voisard JJ
J Cosmet Dermatol; 2019 Feb; 18(1):215-220. PubMed ID: 29659116
[TBL] [Abstract][Full Text] [Related]
27. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men.
Olsen EA; Dunlap FE; Funicella T; Koperski JA; Swinehart JM; Tschen EH; Trancik RJ
J Am Acad Dermatol; 2002 Sep; 47(3):377-85. PubMed ID: 12196747
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of 2% topical minoxidil in the management of male pattern baldness in Chinese.
Kuan YZ; Chen SY; Chen MJ; Wang CN; Chan HL
Changgeng Yi Xue Za Zhi; 1990 Jun; 13(2):96-103. PubMed ID: 2224611
[TBL] [Abstract][Full Text] [Related]
29. Topical minoxidil in male pattern baldness: effects of discontinuation of treatment.
Olsen EA; Weiner MS
J Am Acad Dermatol; 1987 Jul; 17(1):97-101. PubMed ID: 3301926
[TBL] [Abstract][Full Text] [Related]
30. Comparable efficacy of 2% minoxidil gel and solution formulations in the treatment of male pattern alopecia.
Piepkorn MW; Weidner M
J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1059-62. PubMed ID: 3385024
[TBL] [Abstract][Full Text] [Related]
31. Treatment of female androgenetic alopecia with minoxidil 2%.
Whiting DA; Jacobson C
Int J Dermatol; 1992 Nov; 31(11):800-4. PubMed ID: 1428436
[TBL] [Abstract][Full Text] [Related]
32. Topical minoxidil therapy for hereditary male pattern alopecia.
Roenigk HH; Pepper E; Kuruvilla S
Cutis; 1987 Apr; 39(4):337-42. PubMed ID: 3556042
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of 5% minoxidil versus combined 5% minoxidil and 0.01% tretinoin for male pattern hair loss: a randomized, double-blind, comparative clinical trial.
Shin HS; Won CH; Lee SH; Kwon OS; Kim KH; Eun HC
Am J Clin Dermatol; 2007; 8(5):285-90. PubMed ID: 17902730
[TBL] [Abstract][Full Text] [Related]
34. A randomized trial of minoxidil in chemotherapy-induced alopecia.
Duvic M; Lemak NA; Valero V; Hymes SR; Farmer KL; Hortobagyi GN; Trancik RJ; Bandstra BA; Compton LD
J Am Acad Dermatol; 1996 Jul; 35(1):74-8. PubMed ID: 8682968
[TBL] [Abstract][Full Text] [Related]
35. Topical minoxidil therapy for androgenetic alopecia. A 30-month study.
Koperski JA; Orenberg EK; Wilkinson DI
Arch Dermatol; 1987 Nov; 123(11):1483-7. PubMed ID: 3314717
[TBL] [Abstract][Full Text] [Related]
36. The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.
Berger RS; Fu JL; Smiles KA; Turner CB; Schnell BM; Werchowski KM; Lammers KM
Br J Dermatol; 2003 Aug; 149(2):354-62. PubMed ID: 12932243
[TBL] [Abstract][Full Text] [Related]
37. Long-term follow-up of men with male pattern baldness treated with topical minoxidil.
Olsen EA; DeLong ER; Weiner MS
J Am Acad Dermatol; 1987 Mar; 16(3 Pt 2):688-95. PubMed ID: 3549803
[TBL] [Abstract][Full Text] [Related]
38. A Single-Centre, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Investigate the Efficacy and Safety of Minoxidil Topical Foam in Frontotemporal and Vertex Androgenetic Alopecia in Men.
Hillmann K; Garcia Bartels N; Kottner J; Stroux A; Canfield D; Blume-Peytavi U
Skin Pharmacol Physiol; 2015; 28(5):236-44. PubMed ID: 25765348
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.
Suchonwanit P; Iamsumang W; Rojhirunsakool S
Am J Clin Dermatol; 2019 Feb; 20(1):147-153. PubMed ID: 30206824
[TBL] [Abstract][Full Text] [Related]
40. Comparison of efficacy of platelet-rich plasma therapy with or without topical 5% minoxidil in male-type baldness: A randomized, double-blind placebo control trial.
Singh SK; Kumar V; Rai T
Indian J Dermatol Venereol Leprol; 2020; 86(2):150-157. PubMed ID: 31823902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
